Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's or Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00989664
What this trial is testing

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT03188965
What this trial is testing

First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Advanced Solid TumorNon-Hodgkin's LymphomaMantle Cell Lymphoma
Bayer 229
Testing effectiveness (Phase 2)Study completedNCT00117897
What this trial is testing

Treatment for Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Early research (Phase 1)Study completedNCT00052416
What this trial is testing

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Beth Israel Deaconess Medical Center
Early research (Phase 1)Ended earlyNCT01300793
What this trial is testing

Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide

Who this might be right for
Non-Hodgkin's LymphomaB-cell Lymphoma
University of California, San Francisco 6
Testing effectiveness (Phase 2)UnknownNCT01307592
What this trial is testing

Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Auxilio Mutuo Cancer Center 70
Large-scale testing (Phase 3)Active Not RecruitingNCT05171647
What this trial is testing

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Hoffmann-La Roche 208
Testing effectiveness (Phase 2)UnknownNCT05805943
What this trial is testing

Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma

Who this might be right for
CD20-positive B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 154
Early research (Phase 1)UnknownNCT04693676
What this trial is testing

C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
First Affiliated Hospital of Zhejiang University 17
Testing effectiveness (Phase 2)Study completedNCT00087425
What this trial is testing

Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
National Institute on Aging (NIA) 48
Testing effectiveness (Phase 2)Study completedNCT01458288
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

Who this might be right for
Multiple MyelomaNon-hodgkin's LymphomaHodgkin's Disease
GPCR Therapeutics, Inc. 12
Testing effectiveness (Phase 2)UnknownNCT00003942
What this trial is testing

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Systemix 15
Early research (Phase 1)UnknownNCT00004086
What this trial is testing

Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer

Who this might be right for
LeukemiaLymphoma
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Testing effectiveness (Phase 2)Study completedNCT01939327
What this trial is testing

Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Institut Paoli-Calmettes 34
Early research (Phase 1)UnknownNCT05106946
What this trial is testing

Safety and Clinical Activity of ThisCART22 in Patients With r/r Non-Hodgkin's B Cell Lymphoma

Who this might be right for
B-cell Malignancy
Fundamenta Therapeutics, Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT00002488
What this trial is testing

Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy

Who this might be right for
Lymphoma
Ottawa Regional Cancer Centre
Large-scale testing (Phase 3)Active Not RecruitingNCT05409066
What this trial is testing

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Genmab 549
Early research (Phase 1)Study completedNCT01767766
What this trial is testing

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+1 more
TG Therapeutics, Inc. 90
Early research (Phase 1)Ended earlyNCT01032148
What this trial is testing

Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma

Who this might be right for
Hodgkin's LymphomaNon-Hodgkin's Lymphoma
Roswell Park Cancer Institute 8
Not applicableStudy completedNCT05188755
What this trial is testing

Fitness Assessment in Young Adults Recovered From Lymphoma

Who this might be right for
Young AdultsLymphoma, Non-HodgkinHodgkin Disease
University Hospital, Clermont-Ferrand 44
Next Page